Paul Chan Selected Research

trilinolein

6/2005	Molecular mechanism of the inhibitory effect of trilinolein on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytes.
1/2004	Inhibitory effect of trilinolein on angiotensin II-induced cardiomyocyte hypertrophy.
12/2002	Protective effects of trilinolein extracted from panax notoginseng against cardiovascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Chan Research Topics

Disease

10	Hypertension (High Blood Pressure) 10/2017 - 01/2002
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 12/2002
6	Heart Failure 01/2019 - 05/2005
5	Hypercholesterolemia 12/2020 - 01/2017
5	Atrial Fibrillation 01/2019 - 06/2003
4	Hypertrophy 01/2021 - 01/2004
4	Dyslipidemias (Dyslipidemia) 12/2017 - 11/2003
4	Diabetic Nephropathies (Diabetic Nephropathy) 02/2017 - 11/2003
3	Atherosclerosis 01/2022 - 12/2002
3	Insulin Resistance 01/2022 - 02/2005
3	Heart Arrest (Cardiac Arrest) 04/2020 - 10/2012
3	Body Weight (Weight, Body) 02/2020 - 01/2016
3	Neoplasms (Cancer) 01/2017 - 04/2002
3	Reperfusion Injury 12/2015 - 08/2006
2	Pain (Aches) 01/2022 - 08/2005
2	Abdominal Obesity 01/2021 - 11/2003
2	Critical Illness (Critically Ill) 04/2020 - 05/2015
2	Sepsis (Septicemia) 04/2020 - 05/2015
2	Obesity 02/2020 - 10/2016
2	Myocardial Infarction 01/2020 - 02/2003
2	Necrosis 02/2019 - 01/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 09/2016
2	Fibrosis (Cirrhosis) 01/2019 - 06/2009
2	Weight Loss (Weight Reduction) 02/2017 - 01/2016
2	Ischemia 01/2013 - 06/2009
2	Hypoxia (Hypoxemia) 06/2009 - 05/2005
2	Nephrosis 08/2006 - 01/2006
2	Chronic Renal Insufficiency 08/2006 - 01/2006
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2006 - 11/2003
1	Hypoglycemia (Reactive Hypoglycemia) 02/2022
1	Weight Gain 01/2022
1	Injection Site Reaction 12/2021
1	Neuroblastoma 08/2021
1	COVID-19 04/2020
1	Infections 04/2020
1	Pneumonia (Pneumonitis) 04/2020
1	Glioma (Gliomas) 04/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 02/2005
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020 - 12/2005
5	LipidsIBA 01/2020 - 05/2002
5	Angiotensin IIIBA 01/2019 - 01/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2004
3	alirocumabIBA 12/2021 - 01/2017
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2020 - 01/2016
3	oxidized low density lipoproteinIBA 02/2019 - 01/2017
3	Oxygen (Dioxygen)IBA 01/2017 - 08/2002
3	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2012 - 01/2006
3	AntioxidantsIBA 03/2007 - 12/2002
3	Free RadicalsIBA 08/2006 - 08/2002
3	trilinoleinIBA 06/2005 - 12/2002
3	steviosideIBA 02/2005 - 01/2002
2	PPAR gammaIBA 01/2022 - 05/2004
2	evolocumabIBA 12/2021 - 11/2017
2	Adenosine Triphosphate (ATP)IBA 08/2021 - 01/2017
2	Simvastatin (Zocor)FDA LinkGeneric 01/2021 - 01/2019
2	Liraglutide FDA Link 02/2020 - 10/2016
2	Endothelin-1 (Endothelin 1)IBA 01/2019 - 01/2004
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2019
2	Metformin (Glucophage)FDA LinkGeneric 11/2018 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 05/2005
2	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2017 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2016 - 12/2015
2	LactonesIBA 12/2015 - 01/2015
2	parthenolideIBA 12/2015 - 01/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2015 - 01/2014
2	Superoxide DismutaseIBA 03/2007 - 04/2002
2	Antihypertensive Agents (Antihypertensives)IBA 01/2006 - 01/2002
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 03/2002 - 01/2002
1	alogliptinIBA 01/2022
1	Pioglitazone (Actos)FDA Link 01/2022
1	BradykininIBA 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022
1	General AnestheticsIBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	ALN-PCSIBA 12/2021
1	Lidocaine (Xylocaine)FDA LinkGeneric 08/2021
1	cyclopiazonic acidIBA 08/2021
1	HomocysteineIBA 01/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2020
1	QuercetinIBA 04/2020
1	Antineoplastic Agents (Antineoplastics)IBA 04/2020
1	semaglutideIBA 02/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Apolipoprotein B-48IBA 01/2020
1	Ezetimibe (Zetia)FDA Link 06/2019

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2003
3	Glycemic Control 01/2022 - 11/2003
3	Catheter Ablation 05/2005 - 06/2003
2	Resuscitation 04/2020 - 10/2018
2	Cardiopulmonary Resuscitation (CPR) 04/2020 - 10/2012
2	Drug Therapy (Chemotherapy) 02/2020 - 10/2016
2	Subcutaneous Injections 10/2016 - 01/2016
1	Resuscitation Orders (Do Not Resuscitate Orders) 04/2020
1	Artificial Respiration (Mechanical Ventilation) 04/2020
1	Bariatric Surgery 02/2020
1	Injections 02/2020
1	Patient Readmission 01/2020